Sunday, May 26th, 2019

CBD Ban? DEA Tries to Reclassify Non-THC Cannabis Oil as Schedule 1

Published on December 17, 2016 by   ·   1 Comment

cannabis_oil

Makia Freeman

A CBD ban appears to have been put in place by the DEA (Drug Enforcement Administration), an agency of the US Government. Two days ago on their website, they posted a notice that they had made a “new rule,” effective Dec. 14th 2016, to classify “marihuana extract” (their antiquated spelling, not mine) as a Schedule 1 drug. What this means is that CBD (cannabidiol) extracts which have trace amounts of, or absolutely no THC, and are therefore non-psychoactive, are now reclassified to be on par with psychoactive or THC-containing cannabis, heroin, LSD and peyote.

This latent stunt by the DEA is sure to be met with fierce resistance by a legion of Americans who are well aware of the health benefits of the cannabis plant. Legally speaking, the move is also highly dubious in nature, given that the DEA is by definition part of the executive branch of government (tasked with carrying out laws and enforcing them), not the legislative branch of government (tasked with making laws). Does this new rule carry legal weight? Will it amount to a CBD ban?

Kickback from Kratom?

The timing of this move is interesting, given how recently the DEA tried to reschedule another substance: kratom. It was only around 5 months ago that the DEA tried to reclassify kratom by attempting to place it in the dreaded Schedule 1 category. A determined number of Americans fought back and the DEA decided to drop the matter. Some have speculated that the reason may have been to help the DEA’s favorite client, Big Pharma:

The DEA’s recent statement on kratom underlines the extreme lengths to which they will go to continue to assert that they are in the right, even if only to themselves. The agency filed a notice of intent declaring that they would “temporarily schedule the opioids mitragynine and 7-hydroxymitragynine, which are the main active constituents of the plant kratom, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.” The notice then explained, “This action is based on a finding by the Administrator that the placement of these opioids into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety.”

As is typical of bureaucratic agencies, the notice of intent continued in a similar fashion with its convoluted explanation.

And, of course, three synthetic opioids have been synthesized from the kratom plant, namely MGM-9, MGM-15 and MGM-16. Unsurprisingly, these three synthetics were developed from the kratom alkaloids, Mitragynine and 7-Hydroxymitragynine – you know, the ones named by the DEA as an “imminent hazard to public safety.”

If these compounds are so dangerous, why on earth would Big Pharma be synthesizing them to make medicine? It just doesn’t seem to add up, but the federal agency continues to go along with their story of supposed danger to society, hoping we’ll all fall for it. It really tells you all you need to know about the DEA and their relationship with Big Pharma though, doesn’t it?”

In other words, the DEA, like the FDA, are allowing Big Pharma to pursue its business model of biopiracy, i.e. find a plant or something from Nature, study its constituents, learn how to extract them, steal them, modify them and patent them, and then destroy people’s ability to get the original. It’s the synthetic agenda.

Text of the New Rule Regarding CBD from the DEA

Here’s the text of the new rule:

Final Action

After careful consideration of all comments, the DEA is hereby amending 21 CFR 1308.11(d) to include a new subparagraph (58) which creates a new code number in Schedule I as follows:

(58) Marihuana Extract—7350

Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.

The creation of this new drug code in the DEA regulations for marihuana extracts allows for more appropriate accounting of such materials consistent with treaty provisions. Such marihuana Start Printed Page 90196extracts remain in Schedule I. Entities registered to handle marihuana (under drug code 7360) that also handle marihuana extracts, will need to apply to modify their registrations to add the new drug code 7350 to their existing DEA registrations and procure quotas specifically for drug code 7350 each year.

Read More HERE

Share the Truth:
  • Digg
  • Facebook
  • Twitter
  • Google Bookmarks
  • Global Grind
  • MySpace
  • Ping.fm
  • Tumblr
  • email

Readers Comments (1)

  1. maxwood says:

    Besides Big pHARMa, the tobacco $igarette “industry”– still in charge of 15% of the adult US population– has reason to fear normalization of cannabis, the use of which has been driving the trend away from hot burning overdose monoxide $moking toward Vaporization.
    .
    Connection: without $igarette addiction, most of the $135-billion yearly “medical care” cost of “tobacco illness” (2014 Surgeon General Estimate) could be avoided, i.e. massive loss of profits for doctors, hospitals, drug companies.




Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Daily News and Blogs

Listen to the TIS Network on blogtalkradio.com

Check Out Pop Culture Podcasts at Blog Talk Radio with TIS Network on BlogTalkRadio

Like us on Facebook

Advertise Here

Advertise Here